PROTEOMICS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PROTEOMICS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (332)	8/22/2001 12:51:41 PM
From: Jim Oravetz	Read Replies (1) of 539

Oxford GlycoSciences Granted Proteomics Patent In US LONDON -- Oxford GlycoSciences PLC (OGSI), or OGS, said Wednesday it has been granted a patent in the U.S. for its high-throughput proteomics method. The company which develops pharmaceuticals through proteomics - the science of proteins and how they interact and affect the body- said it had obtained U.S. Patent No. 6,278,794, entitled "Computer-Assisted Isolation and Characterization of Proteins." The company said that the patent relates to methods and apparatus for computer-assisted selection and robotic isolation of proteins following two-dimensional separation. OGS added that the patent also covers the use of a laboratory information management system to track samples and results obtained from proteomic analysis. The patent covers more specific intellectual property protection for OGS' proteomics technology than the coverage offered by the more general U.S. Patent No. 6,064,754, which was issued in May 2000, the company added.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next